LAPTM4B

lysosomal protein transmembrane 4 beta

Basic information

Region (hg38): 8:97775057-97853013

Links

ENSG00000104341NCBI:55353OMIM:613296HGNC:13646Uniprot:Q86VI4AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the LAPTM4B gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the LAPTM4B gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
2
clinvar
2
missense
16
clinvar
2
clinvar
18
nonsense
0
start loss
0
frameshift
1
clinvar
1
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 16 2 3

Variants in LAPTM4B

This is a list of pathogenic ClinVar variants found in the LAPTM4B region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
8-97775784-C-T Benign (Jan 19, 2018)775266
8-97775803-G-C not specified Likely benign (Jun 03, 2024)3290105
8-97775833-C-T not specified Uncertain significance (Oct 13, 2023)3117806
8-97775858-G-A not specified Uncertain significance (Jan 25, 2023)2479163
8-97775872-G-A not specified Uncertain significance (Aug 12, 2021)2410603
8-97775926-C-G not specified Uncertain significance (Jan 31, 2024)3117804
8-97775935-C-T not specified Uncertain significance (Nov 10, 2022)2326134
8-97775936-G-C not specified Uncertain significance (Nov 10, 2022)2326135
8-97775937-C-CGGCGGGCTCCAGGCGA not specified Benign (Mar 29, 2016)403028
8-97775979-C-G not specified Likely benign (Aug 02, 2021)2396512
8-97776032-C-G not specified Uncertain significance (May 15, 2023)2523478
8-97776047-A-G not specified Uncertain significance (Oct 04, 2022)2310674
8-97776094-G-C not specified Uncertain significance (Dec 20, 2022)2337680
8-97805403-G-A Benign (Feb 02, 2018)732085
8-97816062-G-A not specified Likely benign (Mar 07, 2023)2454341
8-97816072-G-T not specified Uncertain significance (May 05, 2023)2544157
8-97816076-A-G not specified Uncertain significance (Jun 06, 2023)2557263
8-97816173-G-A not specified Uncertain significance (Jun 17, 2024)3290108
8-97819170-A-G not specified Uncertain significance (Aug 05, 2023)2616611
8-97825061-T-C not specified Uncertain significance (Jan 26, 2022)2273324
8-97825139-A-G not specified Uncertain significance (Apr 25, 2023)2518368
8-97825146-A-G not specified Uncertain significance (Aug 02, 2021)2222280
8-97825152-C-T not specified Uncertain significance (Sep 27, 2021)2351405
8-97851418-G-A not specified Uncertain significance (Mar 25, 2024)3290107

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
LAPTM4Bprotein_codingprotein_codingENST00000445593 777957
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
4.28e-130.0070112552702181257450.000867
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.1131761721.020.000008771984
Missense in Polyphen5662.5880.89473770
Synonymous-0.7297870.21.110.00000384643
Loss of Function-0.8491713.61.256.64e-7158

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.001750.00175
Ashkenazi Jewish0.0006990.000695
East Asian0.000.00
Finnish0.0007880.000739
European (Non-Finnish)0.0009750.000959
Middle Eastern0.000.00
South Asian0.0006100.000523
Other0.003120.00310

dbNSFP

Source: dbNSFP

Function
FUNCTION: Required for optimal lysosomal function (PubMed:21224396). Blocks EGF-stimulated EGFR intraluminal sorting and degradation. Conversely by binding with the phosphatidylinositol 4,5-bisphosphate, regulates its PIP5K1C interaction, inhibits HGS ubiquitination and relieves LAPTM4B inhibition of EGFR degradation (PubMed:25588945). Recruits SLC3A2 and SLC7A5 (the Leu transporter) to the lysosome, promoting entry of leucine and other essential amino acid (EAA) into the lysosome, stimulating activation of proton-transporting vacuolar (V)-ATPase protein pump (V-ATPase) and hence mTORC1 activation (PubMed:25998567). Plays a role as negative regulator of TGFB1 production in regulatory T cells (PubMed:26126825). Binds ceramide and facilitates its exit from late endosome in order to control cell death pathways (PubMed:26280656). {ECO:0000269|PubMed:21224396, ECO:0000269|PubMed:25588945, ECO:0000269|PubMed:25998567, ECO:0000269|PubMed:26126825, ECO:0000269|PubMed:26280656}.;
Pathway
Lysosome - Homo sapiens (human) (Consensus)

Recessive Scores

pRec
0.106

Intolerance Scores

loftool
0.718
rvis_EVS
-0.38
rvis_percentile_EVS
27.69

Haploinsufficiency Scores

pHI
0.488
hipred
N
hipred_score
0.123
ghis
0.494

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.0396

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Laptm4b
Phenotype
growth/size/body region phenotype; homeostasis/metabolism phenotype; embryo phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);

Gene ontology

Biological process
endosome organization;endosome transport via multivesicular body sorting pathway;negative regulation of transforming growth factor beta1 production;regulation of lysosomal membrane permeability;negative regulation of lysosomal protein catabolic process;regulation of lysosome organization
Cellular component
lysosome;lysosomal membrane;endosome;early endosome;plasma membrane;membrane;integral component of membrane;late endosome membrane;multivesicular body membrane;cell projection;multivesicular body, internal vesicle
Molecular function
protein binding;kinase binding;ubiquitin protein ligase binding;ceramide binding;phosphatidylinositol bisphosphate binding